Your browser doesn't support javascript.
loading
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
Kantarjian, Hagop M; Begna, Kebede H; Altman, Jessica K; Goldberg, Stuart L; Sekeres, Mikkael A; Strickland, Stephen A; Arellano, Martha L; Claxton, David F; Baer, Maria R; Gautier, Marc; Berman, Ellin; Seiter, Karen; Solomon, Scott R; Schiller, Gary J; Luger, Selina M; Butrym, Aleksandra; Gaidano, Gianluca; Thomas, Xavier G; Montesinos, Pau; Rizzieri, David A; Quick, Donald P; Venugopal, Parameswaran; Gaur, Rakesh; Maness, Lori J; Kadia, Tapan M; Ravandi, Farhad; Buyse, Marc E; Chiao, Judy H.
Afiliación
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Begna KH; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Altman JK; Department of Medicine, Northwestern University, Chicago, Illinois.
  • Goldberg SL; Hackensack University Medical Center, Hackensack, New Jersey.
  • Sekeres MA; Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, Ohio.
  • Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Arellano ML; Hematology/Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Claxton DF; Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland.
  • Gautier M; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Berman E; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Seiter K; Department of Medicine, New York Medical College, Valhalla, New York.
  • Solomon SR; Northside Hospital Cancer Institute, Leukemia Program, Atlanta, Georgia.
  • Schiller GJ; Hematological Malignancy/Stem Cell Transplant Program, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Luger SM; Department of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Butrym A; Department of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Gaidano G; Division of Hematology, Maggiore della Carita University Hospital, Novara, Italy.
  • Thomas XG; Hematology, South Hospital Center, Lyon, France.
  • Montesinos P; La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Rizzieri DA; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Quick DP; Joe Arrington Cancer Center, Lubbock, Texas.
  • Venugopal P; Department of Medicine, Hematology, and Oncology, Rush University Medical Center, Chicago, Illinois.
  • Gaur R; St Luke's Cancer Institute, Kansas City, Missouri.
  • Maness LJ; Division of Hematology-Oncology Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
  • Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Buyse ME; International Drug Development Institute, Louvain-la-Neuve, Belgium.
  • Chiao JH; Cyclacel Limited, Dundee, United Kingdom.
Cancer ; 127(23): 4421-4431, 2021 12 01.
Article en En | MEDLINE | ID: mdl-34424530
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Arabinonucleósidos / Leucemia Mieloide Aguda Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Arabinonucleósidos / Leucemia Mieloide Aguda Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Humans Idioma: En Año: 2021 Tipo del documento: Article